Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain

Summary

Hair loss occurs commonly as a result of radiotherapy administered to the brain, and this can contribute to the distress and social isolation of patients with advanced cancer. In this study a topical gel will be applied directly to the scalp during each dose of radiotherapy. The goal is to determine to what extent the experimental drug is successful in lessening the hair loss.

Timeline

Start

2008-11

Primary completion

2009-12

Completion

2010-06

Drugs

Indications